Ergoteles LLC Genprex, Inc. Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$1.21 - $2.7 $90,228 - $201,336
-74,569 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$2.59 - $3.36 $151,336 - $196,328
-58,431 Reduced 43.93%
74,569 $200,000
Q2 2021

Aug 12, 2021
BUY
$3.11 - $4.87 $413,630 - $647,710
133,000 New
133,000 $446,000

Others Institutions Holding GNPX

# of Institutions
2
Shares Held
600
Call Options Held
0
Put Options Held
0
View Full List

About Genprex, Inc.

GNPX Quotes by TradingView
  • Ticker GNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,300
  • Market Cap $112M
  • Description
  • Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...
More about GNPX
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email